Novartis AG
Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)
Last updated:
Abstract:
The present invention relates methods of treatment using BMP6 antagonists.
Status:
Grant
Type:
Utility
Filling date:
13 Jun 2017
Issue date:
6 Sep 2022